BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14764675)

  • 1. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background.
    Poe JC; Haas KM; Uchida J; Lee Y; Fujimoto M; Tedder TF
    J Immunol; 2004 Feb; 172(4):2100-10. PubMed ID: 14764675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognate B cell signaling via MHC class II: differential regulation of B cell antigen receptor and MHC class II/Ig-alpha beta signaling by CD22.
    Mills DM; Stolpa JC; Cambier JC
    J Immunol; 2004 Jan; 172(1):195-201. PubMed ID: 14688326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19 signaling pathways play a major role for murine AIDS induction and progression.
    Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
    J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory coreceptors activated by antigens but not by anti-Ig heavy chain antibodies install requirement of costimulation through CD40 for survival and proliferation of B cells.
    Hokazono Y; Adachi T; Wabl M; Tada N; Amagasa T; Tsubata T
    J Immunol; 2003 Aug; 171(4):1835-43. PubMed ID: 12902484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes.
    Lajaunias F; Nitschke L; Moll T; Martinez-Soria E; Semac I; Chicheportiche Y; Parkhouse RM; Izui S
    J Immunol; 2002 Jun; 168(12):6078-83. PubMed ID: 12055217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD22 is a negative regulator of B-cell receptor signalling.
    Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
    Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
    Sato S; Jansen PJ; Tedder TF
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13158-62. PubMed ID: 9371816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
    Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
    J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of marginal zone B cells in CD22-deficient mice.
    Samardzic T; Marinkovic D; Danzer CP; Gerlach J; Nitschke L; Wirth T
    Eur J Immunol; 2002 Feb; 32(2):561-7. PubMed ID: 11828373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
    Bobbitt KR; Justement LB
    J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.
    Sato S; Miller AS; Inaoki M; Bock CB; Jansen PJ; Tang ML; Tedder TF
    Immunity; 1996 Dec; 5(6):551-62. PubMed ID: 8986715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
    Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds.
    Qian Y; Santiago C; Borrero M; Tedder TF; Clarke SH
    J Immunol; 2001 Feb; 166(4):2412-9. PubMed ID: 11160300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.
    Tedder TF; Sato S; Poe JC; Fujimoto M
    Keio J Med; 2000 Mar; 49(1):1-13. PubMed ID: 10750375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction.
    John B; Herrin BR; Raman C; Wang YN; Bobbitt KR; Brody BA; Justement LB
    J Immunol; 2003 Apr; 170(7):3534-43. PubMed ID: 12646615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation.
    Tuscano J; Engel P; Tedder TF; Kehrl JH
    Blood; 1996 Jun; 87(11):4723-30. PubMed ID: 8639842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD22 regulates thymus-independent responses and the lifespan of B cells.
    Otipoby KL; Andersson KB; Draves KE; Klaus SJ; Farr AG; Kerner JD; Perlmutter RM; Law CL; Clark EA
    Nature; 1996 Dec 19-26; 384(6610):634-7. PubMed ID: 8967951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperresponsive B cells in CD22-deficient mice.
    O'Keefe TL; Williams GT; Davies SL; Neuberger MS
    Science; 1996 Nov; 274(5288):798-801. PubMed ID: 8864124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.